Alberta Assets

Alberta is home to numerous organizations that can provide expert support to industry-sponsored clinical trials. Below, you’ll find a listing of organizations sorted by category.

This list is updated monthly and is not meant to be exhaustive database of all Alberta research assets. If you require assistance connecting with any of the organizations listed below or would like to discuss your specific clinical trial needs, contact us.

Explore Alberta’s clinical trial ecosystem.

Scroll through the table below to discover the province’s key assets, from centralized ethics review and real-world data access to specialized research hubs and recruitment infrastructure, that make Alberta a leader in clinical trial innovation.

 

  • Reset

Found 51 Results

Flow Cytometry Facility at Katz Group Center at the University of Alberta

Edmonton
Infrastructure and Equipment
Multiple

The Faculty of Medicine and Dentistry Flow Cytometry Facility is a multi-user facility at the University of Alberta. The facility provides a variety of high quality services for internal and private sector investigators. Today the facility houses 11 instruments (2 FACSArias, an MA900, 3 LSR-Fortessas, an Attune NxT, an Aurora, an ImageStream mkII, an ExoView R200, and a CytoFLEX-S) that offer state-of-the-art analytical flow cytometry, cell sorting, and data analysis.


Child and Adolescent Imaging Research at the University of Calgary

Calgary
Infrastructure and Equipment
Pediatrics

The goal of Child and Adolescent Imaging Research (CAIR) is to develop and implement a comprehensive pediatric imaging research program including key recruitments, state-of-the-art technology, space and skilled staff. Equipment includes a 3T MRI Scanner.


IsletCore at Alberta Diabetes Institute at University of Alberta

Edmonton
Clinical Trial Sites
Registries and Repositories

IsletCore is a campus-based lab that offers pancreatic islet isolations accompanied by various assays of islet function and metabolism. IsletCore provides support or full service for a variety of procedures including: Human pancreatic islet isolation, islet banking, basal characterization of donor islets, and coordination of ethical approvals.


Clinical Research Unit at the Alberta Diabetes Institute at University of Alberta

Edmonton
Clinical Trial Sites
Metabolic Health

The multidisciplinary unit features advanced equipment, including five private clinical exam rooms, a three-bed open day ward, and a blood processing area. It also provices access to specialized facilities like a kitchen/dining room, resting metabolic assessment tools, whole body calorimetry (one of only two in Canada), air displacement plethysmography (BodPod), and dual energy x-ray absorptiometry (DXA).


Cyclotron at Cross Cancer Institute at the University of Alberta

Edmonton
Infrastructure and Equipment
Multiple

There are currently two AHS cyclotrons in Edmonton that produce radiopharmaceuticals for medical use located at: the Cross Cancer Institute and the Medical Isotope and Cyclotron Facility (MICF) at University of Alberta South Campus. These cyclotrons are similar devices but can produce different radioisotopes, offering a more diverse suite of radiopharmaceuticals for medical diagnosis and research. The two cyclotrons in Edmonton have the ability to back each other up during shutdowns or maintenance.


Medical Isotope and Cyclotron Facility at University of Alberta

Edmonton
Infrastructure and Equipment
Multiple

The University of Alberta’s Medical Isotope and Cyclotron Facility can create a steady supply of medical isotopes used to help patients with cancer, cardiac, neurological and other diseases across Alberta and Canada


Alberta Cell Therapy Manufacturing at the Li Ka Shing Centre for Health Research Innovation at the University of Alberta

Edmonton
Infrastructure and Equipment
Multiple

Alberta Cell Therapy Manufacturing (ACTM) is a Contract Development and Manufacturing Organization (CDMO). Our experienced staff are committed to efficiently translating your cell-based therapies from bench to bedside in a cost effective manner. ACTM offers a range of services from technology transfer, process and assay development through to GMP manufacturing for clinical trials. The 10,000 sq. ft. facility was purpose built for GMP manufacturing of cell-based therapies. The cleanroom space is divided into 6 Grade B cleanroom suites with Grade A biological safety cabinets for aseptic processing.


Image Guided Adapted Radiotherapy at the Cross Cancer Institute at the University of Alberta

Edmonton
Infrastructure and Equipment
Oncology

The IGAR program incorporates one of the world’s first MR guided Linac systems, a very-high field (3T) whole body MR Imaging and Spectroscopy System for human studies, an animal 9.4T MR Imaging and Spectroscopy System, an image-fusion laboratory, and the computer laboratories. The MR systems provide the anatomical, functional, metabolic and biochemical information to identify diseases at an earlier stage, and monitor treatment response immediately after and at intervals after treatment. The resultant information is integrated with PET images within our image fusion laboratories to design advanced adaptive radiation therapy delivered by the experimental TomoTherapy system.


Cell Imaging Facility at the Cross Cancer Institute at the University of Alberta

Edmonton
Infrastructure and Equipment
Oncology

The Facility is a multi-user resource providing advanced light microscopy services and transmission electron microscopy services in addition to laser microdissection and micro injection systems and image processing workstations and tools.


nanoFAB Fabrication and Characterization Center at Univeristy of Alberta

Edmonton
Infrastructure and Equipment
Multiple

The nanoFAB is a centralized open-access facility specializing in micro- and nanoscale fabrication and characterization, with over $84 million invested in equipment and infrastructure. Spanning 25,000 sq ft, it houses over 200 pieces of equipment and offers comprehensive capabilities in microscopy, spectroscopy, material analysis, lithography, thin-film deposition, and etching. The facility supports the fabrication of MEMS, sensors, microfluidics, and photonics, with advanced processing capabilities for 4″ (100 mm) and 6″ (150 mm) wafers.


Featured Assets

In collaboration with the provincial government, a number of academic and research organizations have introduced initiatives to position Alberta as an even more attractive destination for conducting clinical trials. These include initiatives to improve start-up times, enhance patient recruitment, centralize trial management and enable access to high-quality medical data.